Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

51 views
Visitors fromUSUS 54%·AUAU 32%·ININ 7%·GBGB 2%·FRFR 2%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

Vetr Announces Plans to Offer ToltraMax Oral Solution Upon Platform Launch

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
GRANTS PASS, OR, May 16, 2025 (EZ Newswire) -- Vetr, an upcoming telehealth platform focused on providing pet owners with access to veterinary products and services, has announced its intention to include ToltraMax, a toltrazuril-based oral solution, as part of its product offerings when the platform launches later this year.

ToltraMax is an oral solution formulated for use in multiple species, including dogs, cats, horses and other non food chain animals. Its active ingredient, toltrazuril, is widely used in veterinary settings to manage intestinal health challenges related to coccidia, a common protozoan parasite affecting a variety of animals.

While Vetr’s platform is still in development, ToltraMax is currently available for purchase through Amazon, Walmart, horseprerace.com, toltrazuril.com, and vetr.com, serving caretakers of equine and companion animals.

“Expanding access to essential veterinary products is a core part of Vetr’s mission,” said Andrew Hamilton, founder and CEO of Vetr. “ToltraMax aligns with our goal of providing practical, broad-use solutions and compounded drugs for pet owners and animal caretakers, making it an important addition to our future product lineup.”

Vetr aims to simplify the process of obtaining veterinary-recommended medications through a digital platform designed for convenience and accessibility. The platform will offer an online pharmacy, educational resources, and telehealth consultations, supporting responsible pet care and providing guidance on product usage.

Recently, Vetr secured $21 million in funding from Palehorse Capital to support the platform’s development and product expansion, including a nationwide online pharmacy. This investment will assist in launching a comprehensive online marketplace for veterinary products, including ToltraMax, alongside efforts to lower the overall cost of pet medications for consumers.

Upon launch, Vetr will provide pet owners with a streamlined purchasing experience, while emphasizing the importance of professional veterinary consultation. The platform will not replace veterinary care but will serve as an additional resource for accessing trusted products and information.

For updates on Vetr’s launch and product availability, visit vetr.com.

About Vetr

Vetr is a telehealth platform transforming pet healthcare by making veterinary services more affordable, accessible and efficient. Through its easy-to-use app, pet owners can schedule appointments, consult remotely with licensed veterinarians and access low-cost, over-the-counter animal prescriptions. Founded by Andrew Hamilton, Vetr is dedicated to delivering high-quality, cost-effective care for pets nationwide. With a focus on generic medications and virtual care, Vetr is redefining how modern pet owners manage their animals’ health. Learn more at vetr.com.

Media Contact

Media Relations
sales@vetr.com
###

SOURCE: Vetr

Copyright 2025 EZ Newswire

See release on EZ Newswire
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  242.67
+0.97 (0.40%)
AAPL  308.63
+14.25 (4.84%)
AMD  517.82
-23.06 (-4.26%)
BAC  58.73
+0.37 (0.63%)
GOOG  356.18
-1.71 (-0.48%)
META  582.90
-30.01 (-4.90%)
MSFT  390.49
+6.21 (1.62%)
NVDA  194.83
-2.75 (-1.39%)
ORCL  140.27
-2.23 (-1.56%)
TSLA  393.45
-31.85 (-7.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.